- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ABR to Offer Dual Radiology Certificate
The ABR will offer a dual primary certificate in interventional and diagnostic radiology, representing a shift in expertise, the ABMS announced.
The American Board of Radiology will now offer a dual primary certificate in interventional and diagnostic radiology, representing a shift in imaging expertise. The certificate was recently approved and announced by the American Board of Medical Specialties.
“The range of diseases to which interventional methods are applied, the responsibility of the practitioner to provide peri-procedural care in both inpatient and outpatient settings, the technical complexity of the interventions and the range of imaging methods used for procedures have all grown significantly in the past two decades,” Gary J. Becker, MD, ABR executive director, said in a statement announcing the training and certification.
Physicians who become board certified in interventional radiology/diagnostic radiology will have:
• Competency in diagnostic imaging to ensure the appropriate, safe and efficacious guidance of current interventional procedures for a wide variety of patients
• Competency in the technical aspects of interventional procedures
• The clinical judgment and skills to participate as team members in the peri-procedural care of patients undergoing interventional radiological procedures
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
